Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Grifols, S.A.
About GRFS
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.
Market Capitalisation
$6.39B
Price-earnings ratio
-
Dividend yield
2.33%
Volume
777.9K
High today
$7.72
Low today
$7.50
Open price
$7.54
52-week high
$11.14
52-week low
$7.36
Ready to start your investing journey with Stake?
Open an accountHow do I buy GRFS shares in Australia?
Buying GRFS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Grifols, S.A. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in GRFS
What is the ticker symbol of Grifols, S.A.?
The ticker symbol for Grifols, S.A. is GRFS.
How much is one share of GRFS?
One share of GRFS is valued at $7.69 as of 13 May 2026.
What is the market capitalisation of Grifols, S.A. GRFS?
As of 13 May 2026 Grifols, S.A. has a market cap of $6.39B.
Does GRFS pay dividends?
Yes, GRFS does pay dividends.
What is the dividend yield for GRFS?
The dividend yield for GRFS is 2.33% as of 13 May 2026.
What is the P/E ratio of GRFS?
The Price to Earnings ratio of GRFS is 9.72.
What is the Earnings Per Share of GRFS?
The Earnings Per Share of GRFS is $0.78.
What is the 52-week high for Grifols, S.A. stock?
The Grifols, S.A. 52-week high stock price is $11.14.
What is the 52-week low for Grifols, S.A. stock?
The Grifols, S.A. 52-week low stock price is $7.36.
Can I buy GRFS shares through Stake, an investing platform like Sharesies and Hatch Invest?
Yes, the Stake investing platform allows you to buy GRFS shares and over 9,500 more stocks and ETFs on Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in GRFS on Stake
- Buy GRFS from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of GRFS from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
GRFS related stocks